Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07699757 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07699757 Clinical Landscape Report 2026
18 September 2026
NCT07699757 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Secukinumab in Diabetes Mellitus, Type 2: NCT07704190 Clinical Landscape Report 2026
9 min read
Secukinumab in Diabetes Mellitus, Type 2: NCT07704190 Clinical Landscape Report 2026
18 September 2026
NCT07704190 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
JS-212 in Advanced Lung Non-Small Cell Carcinoma: NCT07714304 Clinical Landscape Report 2026
9 min read
JS-212 in Advanced Lung Non-Small Cell Carcinoma: NCT07714304 Clinical Landscape Report 2026
18 September 2026
NCT07714304 clinical landscape for Advanced Lung Non-Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
Ferrous Sulfate/Ascorbic Acid in Anemia in chronic kidney disease: TCTR20260721005 Clinical Landscape Report 2026
9 min read
Ferrous Sulfate/Ascorbic Acid in Anemia in chronic kidney disease: TCTR20260721005 Clinical Landscape Report 2026
18 September 2026
TCTR20260721005 clinical landscape for Anemia in chronic kidney disease: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
Radium Ra-223 Dichloride in Castration-sensitive prostate cancer: NCT07717099 Clinical Landscape Report 2026
9 min read
Radium Ra-223 Dichloride in Castration-sensitive prostate cancer: NCT07717099 Clinical Landscape Report 2026
18 September 2026
NCT07717099 clinical landscape for Castration-sensitive prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
Febuxostat in Kidney Diseases: PACTR202607678798356 Clinical Landscape Report 2026
9 min read
Febuxostat in Kidney Diseases: PACTR202607678798356 Clinical Landscape Report 2026
18 September 2026
PACTR202607678798356 clinical landscape for Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Remimazolam Tosylate in Colorectal Cancer: NCT07740343 Clinical Landscape Report 2026
9 min read
Remimazolam Tosylate in Colorectal Cancer: NCT07740343 Clinical Landscape Report 2026
18 September 2026
NCT07740343 clinical landscape for Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Orforglipron in Diabetes Mellitus, Type 2: NCT07739537 Clinical Landscape Report 2026
9 min read
Orforglipron in Diabetes Mellitus, Type 2: NCT07739537 Clinical Landscape Report 2026
18 September 2026
NCT07739537 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Semaglutide (Novo Nordisk) in Localized Prostate Carcinoma: NCT07727473 Clinical Landscape Report 2026
9 min read
Semaglutide (Novo Nordisk) in Localized Prostate Carcinoma: NCT07727473 Clinical Landscape Report 2026
18 September 2026
NCT07727473 clinical landscape for Localized Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Sintilimab in Adenocarcinoma of Lung: NCT07748325 Clinical Landscape Report 2026
9 min read
Sintilimab in Adenocarcinoma of Lung: NCT07748325 Clinical Landscape Report 2026
18 September 2026
NCT07748325 clinical landscape for Adenocarcinoma of Lung: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Amivantamab-VMJM in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07744529 Clinical Landscape Report 2026
9 min read
Amivantamab-VMJM in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07744529 Clinical Landscape Report 2026
18 September 2026
NCT07744529 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
Read →
Paclitaxel in Extensive stage Small Cell Lung Cancer: NCT07744698 Clinical Landscape Report 2026
9 min read
Paclitaxel in Extensive stage Small Cell Lung Cancer: NCT07744698 Clinical Landscape Report 2026
18 September 2026
NCT07744698 clinical landscape for Extensive stage Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →